sc AAV miR26a eGFP Citations (3)

Originally described in: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.
Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT Cell. 2009 Jun 12. 137(6):1005-17. PubMed Journal

---

Articles Citing sc AAV miR26a eGFP

Articles
Starch Binding Domain-containing Protein 1 Plays a Dominant Role in Glycogen Transport to Lysosomes in Liver. Sun T, Yi H, Yang C, Kishnani PS, Sun B. J Biol Chem. 2016 Aug 5;291(32):16479-84. doi: 10.1074/jbc.C116.741397. Epub 2016 Jun 29. PubMed
Low-dose AAV-CRISPR-mediated liver-specific knock-in restored hemostasis in neonatal hemophilia B mice with subtle antibody response. He X, Zhang Z, Xue J, Wang Y, Zhang S, Wei J, Zhang C, Wang J, Urip BA, Ngan CC, Sun J, Li Y, Lu Z, Zhao H, Pei D, Li CK, Feng B. Nat Commun. 2022 Nov 25;13(1):7275. doi: 10.1038/s41467-022-34898-y. PubMed
MicroRNA26a Overexpression Hastens Osteoblast Differentiation Capacity in Dental Stem Cells. Kaufman S, Chang P, Pendleton E, Chandar N. Cell Reprogram. 2023 Jun;25(3):109-120. doi: 10.1089/cell.2023.0004. Epub 2023 May 18. PubMed

If you have published an article using this material, please email us at to have your article added to this page.